TATVA Stock Overview
Engages in manufacture and sale of specialty chemicals in India.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 1/6 |
Tatva Chintan Pharma Chem Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹1,020.25 |
| 52 Week High | ₹1,887.95 |
| 52 Week Low | ₹956.70 |
| Beta | -0.11 |
| 1 Month Change | -6.68% |
| 3 Month Change | -12.67% |
| 1 Year Change | -42.79% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -55.88% |
Recent News & Updates
Weak Statutory Earnings May Not Tell The Whole Story For Tatva Chintan Pharma Chem (NSE:TATVA)
May 11
Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Share Price Matching Investor Opinion
Apr 04Recent updates
Weak Statutory Earnings May Not Tell The Whole Story For Tatva Chintan Pharma Chem (NSE:TATVA)
May 11Tatva Chintan Pharma Chem Limited's (NSE:TATVA) Share Price Matching Investor Opinion
Apr 04These Analysts Just Made A Notable Downgrade To Their Tatva Chintan Pharma Chem Limited (NSE:TATVA) EPS Forecasts
Jan 26Tatva Chintan Pharma Chem Limited (NSE:TATVA) Analysts Are Reducing Their Forecasts For This Year
May 10Tatva Chintan Pharma Chem Limited Just Missed Revenue By 15%: Here's What Analysts Think Will Happen Next
Jul 28Getting In Cheap On Tatva Chintan Pharma Chem Limited (NSE:TATVA) Is Unlikely
Jun 17Investors Shouldn't Be Too Comfortable With Tatva Chintan Pharma Chem's (NSE:TATVA) Robust Earnings
May 03Are Investors Undervaluing Tatva Chintan Pharma Chem Limited (NSE:TATVA) By 45%?
Dec 06Shareholder Returns
| TATVA | IN Chemicals | IN Market | |
|---|---|---|---|
| 7D | -0.7% | 4.5% | 2.7% |
| 1Y | -42.8% | 18.2% | 44.9% |
Return vs Industry: TATVA underperformed the Indian Chemicals industry which returned 18.2% over the past year.
Return vs Market: TATVA underperformed the Indian Market which returned 44.9% over the past year.
Price Volatility
| TATVA volatility | |
|---|---|
| TATVA Average Weekly Movement | 4.7% |
| Chemicals Industry Average Movement | 6.0% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in IN Market | 9.5% |
| 10% least volatile stocks in IN Market | 4.3% |
Stable Share Price: TATVA's share price has been volatile over the past 3 months.
Volatility Over Time: TATVA's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1996 | 608 | Chintan Shah | www.tatvachintan.com |
Tatva Chintan Pharma Chem Limited engages in manufacture and sale of specialty chemicals in India. The company offers a portfolio of structure directing agents for zeolites synthesis; phase transfer catalysts; electrolyte salts for super capacitor and zinc ion batteries; and pharmaceutical APIs, agrochemical products, and other specialty chemicals in the form of intermediates, disinfectants, catalysts, and solvents. It also engages in trading of specialty chemicals.
Tatva Chintan Pharma Chem Limited Fundamentals Summary
| TATVA fundamental statistics | |
|---|---|
| Market cap | ₹23.87b |
| Earnings (TTM) | ₹303.54m |
| Revenue (TTM) | ₹3.94b |
78.6x
P/E Ratio6.1x
P/S RatioIs TATVA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TATVA income statement (TTM) | |
|---|---|
| Revenue | ₹3.94b |
| Cost of Revenue | ₹1.74b |
| Gross Profit | ₹2.19b |
| Other Expenses | ₹1.89b |
| Earnings | ₹303.54m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 12.98 |
| Gross Margin | 55.74% |
| Net Profit Margin | 7.71% |
| Debt/Equity Ratio | 1.9% |
How did TATVA perform over the long term?
See historical performance and comparison